The company «Boehringer Ingelheim», one of the world's leading research and biopharmaceutical development companies, organized an event. The event discussed innovations in healthcare and new treatment methods. Participants highlighted the importance of collaboration between the scientific community and the pharmaceutical industry. One of the speakers noted: «We are on the brink of a breakthrough in the treatment of rare diseases». The company also presented its latest developments in this field.
